RxDoctor Payments Data

Gary Chang

Pain Medicine · Monterey, CANPI 1366411548

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $13,800 of the $18,920 with a category attached, or 72.9%. Boston Scientific accounts for 98.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $11,572 and has fallen 97.5% since, to $289 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,920in general payments, 2019–2025

Across 301 payments — averaging $62.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$19K
  • Otsuka America Pharmaceutical, Inc.$146
  • Nevro Corp.$34
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$26
  • AbbVie$15
  • Abbott$13

What the payments were for

  • Speaking & faculty fees$13,80073%
  • Travel & lodging$7834%
  • Food & beverage$4,33723%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,920 in reported general payments places this provider in the 90th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Other pain medicine in Monterey

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →